1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Kasai, T.
Miyamoto, K.
Tochio, N.
Tomizawa, T.
Koshiba, S.
Watanabe, S.
Harada, T.
Kigawa, T.
Yokoyama, S.
RIKEN Structural Genomics/Proteomics Initiative (RSGI)
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
To be Published
0353
Solution structure of the human STAP2 SH2 domain
10.2210/pdb2el8/pdb
pdb_00002el8
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
13022.834
Signal-transducing adaptor protein 2
SH2 domain
1
man
polymer
STAP-2, Breast tumor kinase substrate, BRK substrate
no
no
GSSGSSGEVLAKEEARRALETPSCFLKVSRLEAQLLLERYPECGNLLLRPSGDGADGVSVTTRQMHNGTHVVRHYKVKRE
GPKYVIDVEQPFSCTSLDAVVNYFVSHTKKALVPFLLD
GSSGSSGEVLAKEEARRALETPSCFLKVSRLEAQLLLERYPECGNLLLRPSGDGADGVSVTTRQMHNGTHVVRHYKVKRE
GPKYVIDVEQPFSCTSLDAVVNYFVSHTKKALVPFLLD
A
hss001002297.1
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
sample
Cell-free protein synthesis
STAP2
9606
Homo sapiens
PLASMID
P061218-22
RIKEN Structural Genomics/Proteomics Initiative
RSGI
NPPSFA, National Project on Protein Structural and Functional Analyses
database_2
pdbx_nmr_software
pdbx_nmr_spectrometer
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Data collection
Database references
Derived calculations
1
0
2007-10-02
1
1
2011-07-13
1
2
2022-03-09
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
_pdbx_nmr_spectrometer.model
_struct_ref_seq_dif.details
Y
PDBJ
Y
PDBJ
2007-03-26
REL
REL
structures with the least restraint violations, structures with the lowest energy, target function
100
20
3D_15N-separated_NOESY
3D_13C-separated_NOESY
120mM
7.0
ambient
298
K
torsion angle dynamics, restrainted molecular dynamics
1
lowest energy
1.00mM SH2 domain U-15N, 13C; 20mM d-Tris-HCl(pH 7.0); 100mM NaCl; 1mM d-DTT; 0.02% NaN3; 90% H2O, 10% D2O
90% H2O/10% D2O
Bruker
collection
XwinNMR
3.5
Delaglio, F.
processing
NMRPipe
20031121
Johnson, B.A.
data analysis
NMRView
5.0.4
Kobayashi, N.
data analysis
KUJIRA
0.9810
Guntert, P.
structure solution
CYANA
2.0.17
Guntert, P.
refinement
CYANA
2.0.17
800
Bruker
AVANCE
GLY
1
n
1
GLY
1
A
SER
2
n
2
SER
2
A
SER
3
n
3
SER
3
A
GLY
4
n
4
GLY
4
A
SER
5
n
5
SER
5
A
SER
6
n
6
SER
6
A
GLY
7
n
7
GLY
7
A
GLU
8
n
8
GLU
8
A
VAL
9
n
9
VAL
9
A
LEU
10
n
10
LEU
10
A
ALA
11
n
11
ALA
11
A
LYS
12
n
12
LYS
12
A
GLU
13
n
13
GLU
13
A
GLU
14
n
14
GLU
14
A
ALA
15
n
15
ALA
15
A
ARG
16
n
16
ARG
16
A
ARG
17
n
17
ARG
17
A
ALA
18
n
18
ALA
18
A
LEU
19
n
19
LEU
19
A
GLU
20
n
20
GLU
20
A
THR
21
n
21
THR
21
A
PRO
22
n
22
PRO
22
A
SER
23
n
23
SER
23
A
CYS
24
n
24
CYS
24
A
PHE
25
n
25
PHE
25
A
LEU
26
n
26
LEU
26
A
LYS
27
n
27
LYS
27
A
VAL
28
n
28
VAL
28
A
SER
29
n
29
SER
29
A
ARG
30
n
30
ARG
30
A
LEU
31
n
31
LEU
31
A
GLU
32
n
32
GLU
32
A
ALA
33
n
33
ALA
33
A
GLN
34
n
34
GLN
34
A
LEU
35
n
35
LEU
35
A
LEU
36
n
36
LEU
36
A
LEU
37
n
37
LEU
37
A
GLU
38
n
38
GLU
38
A
ARG
39
n
39
ARG
39
A
TYR
40
n
40
TYR
40
A
PRO
41
n
41
PRO
41
A
GLU
42
n
42
GLU
42
A
CYS
43
n
43
CYS
43
A
GLY
44
n
44
GLY
44
A
ASN
45
n
45
ASN
45
A
LEU
46
n
46
LEU
46
A
LEU
47
n
47
LEU
47
A
LEU
48
n
48
LEU
48
A
ARG
49
n
49
ARG
49
A
PRO
50
n
50
PRO
50
A
SER
51
n
51
SER
51
A
GLY
52
n
52
GLY
52
A
ASP
53
n
53
ASP
53
A
GLY
54
n
54
GLY
54
A
ALA
55
n
55
ALA
55
A
ASP
56
n
56
ASP
56
A
GLY
57
n
57
GLY
57
A
VAL
58
n
58
VAL
58
A
SER
59
n
59
SER
59
A
VAL
60
n
60
VAL
60
A
THR
61
n
61
THR
61
A
THR
62
n
62
THR
62
A
ARG
63
n
63
ARG
63
A
GLN
64
n
64
GLN
64
A
MET
65
n
65
MET
65
A
HIS
66
n
66
HIS
66
A
ASN
67
n
67
ASN
67
A
GLY
68
n
68
GLY
68
A
THR
69
n
69
THR
69
A
HIS
70
n
70
HIS
70
A
VAL
71
n
71
VAL
71
A
VAL
72
n
72
VAL
72
A
ARG
73
n
73
ARG
73
A
HIS
74
n
74
HIS
74
A
TYR
75
n
75
TYR
75
A
LYS
76
n
76
LYS
76
A
VAL
77
n
77
VAL
77
A
LYS
78
n
78
LYS
78
A
ARG
79
n
79
ARG
79
A
GLU
80
n
80
GLU
80
A
GLY
81
n
81
GLY
81
A
PRO
82
n
82
PRO
82
A
LYS
83
n
83
LYS
83
A
TYR
84
n
84
TYR
84
A
VAL
85
n
85
VAL
85
A
ILE
86
n
86
ILE
86
A
ASP
87
n
87
ASP
87
A
VAL
88
n
88
VAL
88
A
GLU
89
n
89
GLU
89
A
GLN
90
n
90
GLN
90
A
PRO
91
n
91
PRO
91
A
PHE
92
n
92
PHE
92
A
SER
93
n
93
SER
93
A
CYS
94
n
94
CYS
94
A
THR
95
n
95
THR
95
A
SER
96
n
96
SER
96
A
LEU
97
n
97
LEU
97
A
ASP
98
n
98
ASP
98
A
ALA
99
n
99
ALA
99
A
VAL
100
n
100
VAL
100
A
VAL
101
n
101
VAL
101
A
ASN
102
n
102
ASN
102
A
TYR
103
n
103
TYR
103
A
PHE
104
n
104
PHE
104
A
VAL
105
n
105
VAL
105
A
SER
106
n
106
SER
106
A
HIS
107
n
107
HIS
107
A
THR
108
n
108
THR
108
A
LYS
109
n
109
LYS
109
A
LYS
110
n
110
LYS
110
A
ALA
111
n
111
ALA
111
A
LEU
112
n
112
LEU
112
A
VAL
113
n
113
VAL
113
A
PRO
114
n
114
PRO
114
A
PHE
115
n
115
PHE
115
A
LEU
116
n
116
LEU
116
A
LEU
117
n
117
LEU
117
A
ASP
118
n
118
ASP
118
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
LEU
47
A
N
LEU
47
A
O
THR
61
A
O
THR
61
A
N
THR
62
A
N
THR
62
A
O
ARG
73
A
O
ARG
73
1
A
GLU
8
-53.34
174.46
1
A
VAL
9
-37.20
-30.05
1
A
LEU
10
33.16
46.13
1
A
ARG
17
34.85
45.56
1
A
LEU
31
-37.22
-36.53
1
A
ALA
33
-39.42
-27.01
1
A
CYS
43
-86.10
38.25
1
A
SER
51
-63.86
-179.61
1
A
ASN
67
43.08
26.32
1
A
PRO
82
-69.70
3.37
1
A
PRO
91
-69.75
82.30
1
A
ALA
111
-69.55
96.27
2
A
LEU
10
-68.91
94.33
2
A
LYS
12
34.15
33.70
2
A
ALA
33
-37.54
-37.73
2
A
TYR
40
-117.61
79.79
2
A
ASN
67
41.79
29.92
2
A
ASP
87
-90.16
41.29
2
A
PRO
91
-69.76
85.05
2
A
PHE
92
-60.64
98.55
2
A
ALA
111
-51.33
100.64
3
A
ARG
17
-102.51
50.09
3
A
ASP
53
-102.54
-64.88
3
A
ASP
56
-54.25
94.12
3
A
PRO
82
-69.81
0.93
3
A
ILE
86
-42.27
152.36
3
A
PRO
91
-69.79
88.96
4
A
ALA
18
-114.38
73.86
4
A
SER
29
-68.47
-179.92
4
A
MET
65
-41.98
100.32
4
A
ASP
87
-87.34
42.91
4
A
PRO
91
-69.67
88.33
4
A
LYS
109
-49.95
-70.28
5
A
LEU
10
-54.15
99.89
5
A
LYS
12
-82.04
38.94
5
A
ASN
45
-131.50
-40.68
5
A
ASP
87
-91.14
45.60
5
A
PRO
91
-69.74
93.02
5
A
HIS
107
-41.59
-70.09
6
A
LYS
12
32.04
36.53
6
A
PHE
25
-44.50
156.12
6
A
TYR
40
-119.62
78.98
6
A
SER
51
-51.57
179.42
6
A
PRO
82
-69.81
3.07
6
A
ASP
87
-82.81
46.42
6
A
PRO
91
-69.76
86.80
7
A
LEU
10
-50.48
94.36
7
A
ALA
11
-36.31
153.79
7
A
LYS
12
-39.00
116.36
7
A
ARG
17
-89.51
43.24
7
A
SER
51
-95.91
38.45
7
A
ASP
56
34.45
43.38
7
A
ILE
86
-47.92
156.08
7
A
ASP
87
-91.69
46.38
7
A
PRO
91
-69.81
86.38
7
A
ALA
111
-43.35
99.75
8
A
ALA
11
-46.71
174.76
8
A
LYS
12
-53.59
103.27
8
A
ARG
17
34.24
39.63
8
A
ASP
53
-124.80
-58.34
8
A
ASN
67
71.30
36.71
8
A
PRO
82
-69.84
2.96
8
A
PRO
91
-69.81
90.41
8
A
ALA
111
-59.83
109.00
9
A
LYS
12
33.37
33.31
9
A
ALA
18
70.05
36.61
9
A
ASN
45
-130.88
-32.00
9
A
PRO
82
-69.82
2.86
9
A
PRO
91
-69.73
89.01
10
A
LYS
12
37.33
41.47
10
A
ALA
18
-108.69
65.52
10
A
TYR
40
-108.71
78.77
10
A
ASP
53
-96.80
42.23
10
A
MET
65
-69.19
97.99
10
A
PRO
82
-69.70
2.71
10
A
ASP
87
-68.09
74.32
10
A
PRO
91
-69.74
89.18
10
A
THR
108
-58.66
-177.07
10
A
LYS
109
-40.78
151.53
10
A
LYS
110
-33.05
-34.91
11
A
GLU
8
-49.96
-179.16
11
A
VAL
9
-34.22
113.38
11
A
ARG
17
-76.63
48.18
11
A
ALA
18
-93.02
58.77
11
A
PHE
25
-43.76
154.56
11
A
ASP
56
-98.58
41.42
11
A
PRO
91
-69.81
86.39
11
A
LYS
110
-41.92
163.69
12
A
VAL
9
-35.13
-34.17
12
A
LEU
10
33.50
50.94
12
A
ARG
17
-50.95
171.90
12
A
ALA
33
-36.50
-35.69
12
A
PRO
91
-69.74
88.19
13
A
ALA
11
-55.14
-175.31
13
A
ARG
17
-77.62
47.60
13
A
LEU
19
-109.52
-63.18
13
A
GLU
20
-38.72
-37.60
13
A
GLU
32
-36.75
-39.77
13
A
CYS
43
-85.59
37.93
13
A
ASN
45
-132.92
-52.62
13
A
LEU
46
-50.07
89.46
13
A
PRO
91
-69.71
85.50
13
A
THR
108
-54.54
-174.98
14
A
ALA
15
38.30
26.31
14
A
PHE
25
-49.38
152.10
14
A
ALA
33
-34.06
-38.53
14
A
TYR
40
-119.13
76.59
14
A
ASN
67
39.30
41.28
14
A
PRO
91
-69.67
85.01
15
A
GLU
8
-48.31
-18.99
15
A
VAL
9
-173.64
143.34
15
A
ARG
17
-91.22
59.55
15
A
PHE
25
-45.98
153.16
15
A
TYR
40
-114.08
76.52
15
A
HIS
66
-69.81
-178.88
15
A
ASN
67
-33.66
-39.24
15
A
PRO
82
-69.75
3.02
15
A
PRO
91
-69.68
86.36
16
A
LEU
10
-87.74
44.74
16
A
ALA
33
-33.84
-38.21
16
A
TYR
40
-116.30
78.14
16
A
CYS
43
-84.34
35.69
16
A
LEU
46
-64.19
98.36
16
A
ASN
67
-33.32
93.00
16
A
PRO
91
-69.78
86.57
16
A
VAL
105
-35.86
-33.35
16
A
THR
108
-34.27
131.20
16
A
LEU
112
-162.35
110.17
17
A
ARG
17
34.11
53.21
17
A
ALA
33
-34.06
-33.26
17
A
ASN
45
-132.32
-32.54
17
A
PRO
82
-69.89
2.02
17
A
PRO
91
-69.80
91.94
17
A
THR
108
-36.84
155.82
17
A
LYS
109
-33.29
-75.13
18
A
SER
2
-170.59
136.13
18
A
SER
5
-173.47
114.49
18
A
ALA
11
-37.06
-72.75
18
A
LYS
12
-163.49
105.04
18
A
ARG
17
-55.57
96.50
18
A
TYR
40
-119.54
71.45
18
A
ASP
53
-125.16
-54.11
18
A
ASN
67
45.34
28.89
18
A
PRO
82
-69.81
2.50
18
A
ASP
87
-89.52
43.87
18
A
PRO
91
-69.69
81.02
18
A
ALA
111
-34.59
113.19
19
A
PHE
25
-45.48
152.50
19
A
ALA
33
-34.59
-37.49
19
A
ASP
87
-93.29
52.53
19
A
PRO
91
-69.69
85.96
20
A
SER
6
-101.01
40.36
20
A
ALA
15
-170.95
141.10
20
A
ARG
17
-86.52
41.73
20
A
PHE
25
-46.96
150.07
20
A
GLN
34
-59.51
-70.26
20
A
CYS
43
-87.30
35.53
20
A
ASN
45
-130.04
-44.06
20
A
LEU
46
-58.04
89.60
20
A
ASP
53
-90.07
48.40
20
A
ASP
87
-94.79
45.85
20
A
PRO
91
-69.68
87.05
20
A
ALA
111
-54.55
104.07
Solution structure of the human STAP2 SH2 domain
1
N
N
A
SER
29
A
SER
29
HELX_P
A
TYR
40
A
TYR
40
1
1
12
A
SER
96
A
SER
96
HELX_P
A
THR
108
A
THR
108
1
2
13
SIGNALING PROTEIN
SH2 domain, Phosphotyrosine binding domain, Protein Tyrosine Kinase, Signal Transduction, Structural Genomics, NPPSFA, National Project on Protein Structural and Functional Analyses, RIKEN Structural Genomics/Proteomics Initiative, RSGI, SIGNALING PROTEIN
STAP2_HUMAN
UNP
1
137
Q9UGK3
EVLAKEEARRALETPSCFLKVSRLEAQLLLERYPECGNLLLRPSGDGADGVSVTTRQMHNGTHVVRHYKVKREGPKYVID
VEQPFSCTSLDAVVNYFVSHTKKALVPFLLD
137
247
2EL8
8
118
Q9UGK3
A
1
8
118
1
expression tag
GLY
1
2EL8
A
Q9UGK3
UNP
1
1
expression tag
SER
2
2EL8
A
Q9UGK3
UNP
2
1
expression tag
SER
3
2EL8
A
Q9UGK3
UNP
3
1
expression tag
GLY
4
2EL8
A
Q9UGK3
UNP
4
1
expression tag
SER
5
2EL8
A
Q9UGK3
UNP
5
1
expression tag
SER
6
2EL8
A
Q9UGK3
UNP
6
1
expression tag
GLY
7
2EL8
A
Q9UGK3
UNP
7
3
anti-parallel
anti-parallel
A
LEU
47
A
LEU
47
A
PRO
50
A
PRO
50
A
VAL
58
A
VAL
58
A
THR
62
A
THR
62
A
ARG
73
A
ARG
73
A
TYR
75
A
TYR
75